146 related articles for article (PubMed ID: 7384094)
1. Requirements for an idealized animal model of prostatic cancer.
Coffey DS; Isaacs JT
Prog Clin Biol Res; 1980; 37():379-91. PubMed ID: 7384094
[TBL] [Abstract][Full Text] [Related]
2. The Nb rat prostatic adenocarcinoma model system.
Drago JR; Goldman LB; Maurer RE
Prog Clin Biol Res; 1980; 37():265-91. PubMed ID: 7384086
[TBL] [Abstract][Full Text] [Related]
3. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
5. Concepts in prostatic cancer biology: Dunning R-3327 H, HI, and AT tumors.
Isaacs JT; Weissman RM; Coffey DS; Scott WW
Prog Clin Biol Res; 1980; 37():311-23. PubMed ID: 7384091
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice.
Mickey DD; Stone KR; Wunderli H; Mickey GH; Paulson DF
Prog Clin Biol Res; 1980; 37():67-84. PubMed ID: 7384095
[No Abstract] [Full Text] [Related]
7. Immunological studies of prostate adenocarcinoma in an animal model.
Claflin AJ; McKinney EC; Fletcher MA
Prog Clin Biol Res; 1980; 37():365-77. PubMed ID: 7384093
[No Abstract] [Full Text] [Related]
8. Characterization of animal tumors: summary.
Bogden AE
Prog Clin Biol Res; 1980; 37():303-10. PubMed ID: 7384089
[No Abstract] [Full Text] [Related]
9. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
Wikström P; Lindahl C; Bergh A
Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
[TBL] [Abstract][Full Text] [Related]
10. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration.
Frost GI; Lustgarten J; Dudouet B; Nyberg L; Hartley-Asp B; Borgström P
Microvasc Res; 2005 Jan; 69(1-2):1-9. PubMed ID: 15797254
[TBL] [Abstract][Full Text] [Related]
11. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
Hsieh CL; Chung LW
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
[TBL] [Abstract][Full Text] [Related]
12. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
Drago JR; Goldman LB; Maurer RE; Eckels DD; Gershwin ME
J Natl Cancer Inst; 1980 Apr; 64(4):931-7. PubMed ID: 6929004
[No Abstract] [Full Text] [Related]
13. The LNCaP cell line--a new model for studies on human prostatic carcinoma.
Horoszewicz JS; Leong SS; Chu TM; Wajsman ZL; Friedman M; Papsidero L; Kim U; Chai LS; Kakati S; Arya SK; Sandberg AA
Prog Clin Biol Res; 1980; 37():115-32. PubMed ID: 7384082
[No Abstract] [Full Text] [Related]
14. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer.
Kasper S; Smith JA
J Urol; 2004 Jul; 172(1):12-9. PubMed ID: 15201729
[TBL] [Abstract][Full Text] [Related]
15. Animal model of human disease: metastic adenocarcinoma of the prostate.
Pollard M
Am J Pathol; 1977 Jan; 86(1):277-80. PubMed ID: 831516
[No Abstract] [Full Text] [Related]
16. [In vitro and in vivo models developed from human prostatic cancer].
Bladou F; Gleave ME; Penault-Llorca F; Serment G; Lange PH; Vessella RL
Prog Urol; 1997 Jun; 7(3):384-96. PubMed ID: 9273065
[TBL] [Abstract][Full Text] [Related]
17. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
Weeraratna AT; Dalrymple SL; Lamb JC; Denmeade SR; Miknyoczki S; Dionne CA; Isaacs JT
Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797
[TBL] [Abstract][Full Text] [Related]
18. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
Kasper S
J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
[TBL] [Abstract][Full Text] [Related]
19. Prostate tumor biology and cell kinetics--theory.
Coffey DS; Isaacs JT
Urology; 1981 Mar; 17(Suppl 3):40-53. PubMed ID: 7010755
[No Abstract] [Full Text] [Related]
20. Animal models of prostate cancer.
Russell PJ; Voeks DJ
Methods Mol Med; 2003; 81():89-112. PubMed ID: 12725117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
